Sort
64,565 grants matching “drug discovery”
Therapy for NF1-Related Tumors and other Genetic Tumor Predisposition Syndromes
$1,005,177Brigitte Widemann · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Nuclear Factor-kappaB in Ovarian Cancer
$1,005,082Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Defining the Chemical Perturbome of Neural Development and Activity
$1,005,000Summer B Thyme · Univ Of Massachusetts Med Sch Worcester · DP2 · FY2025 · NS
The Identification and characterization of genetic variants underlying cardiovascular diseases
$1,005,000Arya Mani · Yale University · R35 · FY2023 · HL
The Identification and characterization of genetic variants underlying cardiovascular diseases
$1,005,000Arya Mani · Yale University · R35 · FY2018 · HL
The Identification and characterization of genetic variants underlying cardiovascular diseases
$1,005,000Arya Mani · Yale University · R35 · FY2021 · HL
The Identification and characterization of genetic variants underlying cardiovascular diseases
$1,005,000Arya Mani · Yale University · R35 · FY2017 · HL
The Identification and characterization of genetic variants underlying cardiovascular diseases
$1,005,000Arya Mani · Yale University · R35 · FY2019 · HL
The Identification and characterization of genetic variants underlying cardiovascular diseases
$1,005,000Arya Mani · Yale University · R35 · FY2020 · HL
The Identification and characterization of genetic variants underlying cardiovascular diseases
$1,005,000Arya Mani · Yale University · R35 · FY2022 · HL
Development and implementation of multiplex methods to understand the biology and heterogeneity of patient-derived cancer models
$1,004,910William C Hahn · Dana-Farber Cancer Inst · U01 · FY2020 · CA
Functional Genomic Discovery of Pathway Targeted and Immune Modulatory Therapeutic Combinations in Hematologic Malignancies
$1,004,845Brian J Druker · Oregon Health & Science University · U01 · FY2017 · CA
Functional Genomic Discovery of Pathway Targeted and Immune Modulatory Therapeutic Combinations in Hematologic Malignancies
$1,004,844Brian J Druker · Oregon Health & Science University · U01 · FY2020 · CA
Functional Genomic Discovery of Pathway Targeted and Immune Modulatory Therapeutic Combinations in Hematologic Malignancies
$1,004,844Brian J Druker · Oregon Health & Science University · U01 · FY2018 · CA
Functional Genomic Discovery of Pathway Targeted and Immune Modulatory Therapeutic Combinations in Hematologic Malignancies
$1,004,844Brian J Druker · Oregon Health & Science University · U01 · FY2021 · CA
Medicinal Chemistry Core
$1,004,802John Schneekloth · Division Of Basic Sciences - Nci · ZIC · FY2023 · CA
Development Of Theoretical Methods For Studying Biological Macromolecules
$1,004,608Bernard R Brooks · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL
Targeting the checkpoint regulator VISTA for treatment of inflammatory disease
$1,004,563Jay L Rothstein · Immunext, Inc. · R44 · FY2019 · AI
Advancing KNX100 for the treatment of opioid withdrawal: preclinical efficacy and toxicology, and a phase 1 clinical program.
$1,004,351Hugh William Alsop · Kinoxis Therapeutics Pty Ltd · UH3 · FY2024 · DA
Development of ultra-efficient antibodies for single cell mapping applications
$1,004,302Andrea Lynn Johnstone · Epicypher, Inc. · R44 · FY2025 · AI
Predevelopment of VV2003, a Novel CRAC Channel Inhibitor, to Improve Outcomes Associated with Checkpoint Inhibitor Immunotherapy
$1,004,278Milton L Greenberg · Vivreon Biosciences, Llc · R44 · FY2019 · CA
Imaging Probe Development Center
$1,004,245Rolf Swenson · National Heart, Lung, And Blood Institute · ZIC · FY2019 · HL
Rational design of bifunctional protein degrader drugs
$1,004,186Karteek Kadimisetty · Lifesensors, Inc. · R44 · FY2021 · GM
SRI TO 13 - CONTINUOUS RODENT AND NON-RODENT PHARMACOKINETIC ASSESSMENTS
$1,003,731Carol Green · Sri International · N01 · FY2024 · DA
Antifibrotic Therapy for Chronic Kidney Disease
$1,002,967Prakash Narayan · Angion Biomedica Corporation · R44 · FY2013 · DK